Concepedia

Author

Elizabeth Schappell

Johns Hopkins University

Also Known As

Elizabeth A. Schappell, Elizabeth Schappell

23

Publications

803

Citations

15

H-Index

9

Concepts

All Affiliations

Johns Hopkins UniversityNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthJohns Hopkins HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development
ES

About

Elizabeth Schappell is an author at Johns Hopkins University specializing in immunology, virology, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

219

2

Immunology

3

3

219

3

Vaccine Development

3

3

219

4

Infection Control

1

1

45

5

Influenza Vaccines

1

1

118

Elizabeth Schappell

×

16

Publications

782

Citations

15

H-Index

YearCitations

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults

Ruth A. Karron, Kawsar R. Talaat, Catherine J. Luke,

Vaccine

2009

118

A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults

Ruth A. Karron, Karen Callahan, Catherine J. Luke,

The Journal of Infectious Diseases

2009

70

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan,

The Journal of Infectious Diseases

2018

70

Comparison of Temple Temperatures with Rectal Temperatures in Children Under Two Years of Age

George K. Siberry, Marie Diener‐West, Elizabeth Schappell,

Clinical Pediatrics

2002

62

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

Ursula J. Buchholz, Coleen K. Cunningham, Petronella Muresan,

The Journal of Infectious Diseases

2018

59

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children

Ruth A. Karron, Bhagvanji Thumar, Elizabeth Schappell,

Vaccine

2011

56

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan,

The Journal of Infectious Diseases

2020

53

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan,

The Journal of Infectious Diseases

2019

46

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

Janet A. Englund, Ruth A. Karron, Coleen K. Cunningham,

Vaccine

2013

45

Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children

Coleen K. Cunningham, Ruth A. Karron, Petronella Muresan,

The Journal of Infectious Diseases

2022

43

Page 1